www.fdanews.com/articles/120679-lilly-selling-rights-to-medicine

Lilly Selling Rights to Medicine

September 22, 2009

Adolor Corp. is paying as much as $72 million for rights to Eli Lilly and Co.’s OpRA III, an experimental medicine to restore bowel function in people taking narcotic painkillers.
IndyStar